Atlas Trials

Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer

Clinical trial NCT04966143 · UNKNOWN

Trial details

NCT number
NCT04966143
Sponsor
Shanghai Longyao Biotechnology Inc., Ltd.
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2021-08-01
Primary completion
2023-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.